Memory B cells and CD8+ lymphocytes do not control seasonal influenza a virus replication after homologous Re-Challenge of rhesus macaques

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Carroll, Timothy D ^a,b   Matzinger, Shannon R ^a,b   Fritts, Linda ^a,b   McChesney, Michael B ^a,b,d   Miller, Christopher J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD8ALPHA ANTIGEN; OKT 8; CD20 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA A; INFLUENZA VIRUS A; INNATE IMMUNITY; INOCULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; NONHUMAN; PROVOCATION TEST; RHESUS MONKEY; SEASONAL INFLUENZA; VIRUS HEMAGGLUTINATION; VIRUS REPLICATION; ANIMAL; B LYMPHOCYTE; CYTOLOGY; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; MACACA MULATTA; NATURAL KILLER CELL; PHYSIOLOGY; SEASON; SPECIES DIFFERENCE; VIROLOGY;

ANIMALIA; INFLUENZA A VIRUS; MACACA MULATTA; PRIMATES;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTIGENS, CD8; B-LYMPHOCYTE SUBSETS; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNITY, INNATE; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; KILLER CELLS, NATURAL; MACACA MULATTA; SEASONS; SPECIES SPECIFICITY; VIRUS REPLICATION;

EID: 79959660983     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021756     Document Type: Article

References (40)

1. Wright PF, Neumann G, Kawaoka Y, (2007) Orthomyxoviruses. In: Knipe DM, Howley PM, editors. Fields Virology. 5th ed Wolters Kluwer {pipe} Lippincott Williams & Wilkins pp. 1691-1740.
2. Couch RB, (2003) An overview of serum antibody responses to influenza virus antigens. Dev Biol (Basel) 115: 25-30.
3. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, et al. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101: 643-649.
4. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A, (2000) Human memory CTL response specific for influenza A virus is broad and multispecific. Hum Immunol 61: 438-452.
5. Greenberg SB, Couch RB, Kasel JA, (1974) An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness. Am J Epidemiol 100: 209-215.
6. Hartley CA, Reading PC, Ward AC, Anders EM, (1997) Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch Virol 142: 75-88.
7. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, et al. (2009) Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325: 484-487.
8. Kugel D, Kochs G, Obojes K, Roth J, Kobinger GP, et al. (2009) Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol 83: 3843-3851.
9. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V, (2008) Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 376: 53-59.
10. Lowen AC, Mubareka S, Steel J, Palese P, (2007) Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 3: 1470-1476.
11. Berendt RF, (1974) Simian model for the evaluation of immunity to influenza. Infect Immun 9: 101-105.
12. Carroll TD, Matzinger SR, Genesca M, Fritts L, Colon R, et al. (2008) Interferon-induced expression of MxA in the respiratory tract of rhesus macaques is suppressed by influenza virus replication. J Immunol 180: 2385-2395.
13. Baskin CR, Bielefeldt-Ohmann H, Garcia-Sastre A, Tumpey TM, Van Hoeven N, et al. (2007) Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza Virus. J Virol 81: 11817-11827.
14. Rimmelzwaan GF, Baars M, van Beek R, van Amerongen G, Lovgren-Bengtsson K, et al. (1997) Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J Gen Virol 78: 757-765.
15. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, et al. (2001) Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 75: 6687-6691.
16. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319-323.
17. Genesca M, McChesney MB, Miller CJ, (2009) Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6. J Intern Med 265: 67-77.
18. Miller CJ, Genesca M, Abel K, Montefiori D, Forthal D, et al. (2007) Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. J Virol 81: 5024-5035.
19. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am J Hygiene 27: 493-497.
20. Miller CJ, McChesney MB, Lu X, Dailey PJ, Chutkowski C, et al. (1997) Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol 71: 1911-1921.
21. Abel K, Rocke DM, Chohan B, Fritts L, Miller CJ, (2005) Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol 79: 12164-12172.
22. Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, et al. (2005) The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol 79: 14355-14370.
23. Genescà M, Skinner PJ, Hong JJ, Li J, Lu D, et al. (2008) With minimal systemic T cell expansion, CD8+ T cells mediate protection from vaginal SIV challenge in rhesus macaques immunized with attenuated SHIV89.6. J Virology 82: 11181-11196.
24. Gaufin T, Gautam R, Kasheta M, Ribeiro R, Ribka E, et al. (2009) Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain. Blood 113: 4250-4261.
25. Schmitz JE, Johnson RP, McClure HM, Manson KH, Wyand MS, et al. (2005) Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques. J Virol 79: 8131-8141.
26. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
27. Schmitz JE, Kuroda MJ, Santra S, Simon MA, Lifton MA, et al. (2003) Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus. J Virol 77: 2165-2173.
28. Schmitz JE, Simon MA, Kuroda MJ, Lifton MA, Ollert MW, et al. (1999) A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 154: 1923-1932.
29. Tedder TF, Engel P, (1994) CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today 15: 450-454.
30. Tedder TF, Zhou LJ, Engel P, (1994) The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 15: 437-442.
31. Salk JE, (1944) A Simplified Procedure For Titrating Hemagglutination Capacity of Influenza-Virus and the Corresponding Antibody. Journal of Immunology 49: 87-98.
32. Miller DL, Reid D, Daimond JR, Pereira MS, Chakraverty P, (1973) Hong Kong influenza in the Royal Air Force 1968-70. J Hyg (Lond) 71: 535-547.
33. Pyhala R, Aho K, (1975) Serum HI antibody and protection against influenza: a follow-up survey at community level of three epidemics caused by different H3N2-variants. Int J Epidemiol 4: 127-129.
34. Fox JP, Cooney MK, Hall CE, Foy HM, (1982) Influenza virus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 116: 228-242.
35. Delem A, Jovanovic D, (1978) Correlation between rate of infection and preexisting titer of serum antibody as determined by single radial hemolysis during and epidemic of influenza A/Victoria/3/75. J Infect Dis 137: 194-196.
36. Hobson D, Curry RL, Beare AS, Ward-Gardner A, (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767-777.
37. Carroll TD, Matzinger SR, Barro M, Fritts L, McChesney MB, et al. (2010) Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone® in rhesus macaques. Vaccine.
38. Couch RB, Kasel JA, (1983) Immunity to influenza in man. Annu Rev Microbiol 37: 529-549.
39. Glezen WP, Couch RB, Six HR, (1982) The influenza herald wave. Am J Epidemiol 116: 589-598.
40. Manz RA, Hauser AE, Hiepe F, Radbruch A, (2005) Maintenance of serum antibody levels. Annu Rev Immunol 23: 367-386.